Our Mission

Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 125 years later, the company operates globally with 145 affiliates and more than 47,000 employees. Since its founding, the privately-held company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.

Our Objectives

The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us build on our strengths and make the most of our distinctive character and corporate culture that is rooted in our belief that in order to be successful we must have a strong partnership with our people.

Value through Innovation is what drives us to continuously search for new and innovative ways to improve the lives that we touch - whether that be lives of patients and their families, our employees or our community.  Boehringer Ingelheim is also committed to providing valuable services and support to patients and their families. 

Our Commitment to Patients

All of Boehringer Ingelheim’s efforts are focused on improving patients’ lives.  We succeed by understanding patients’ needs, and meeting those needs with innovative medicines and best-in-class engagements, programs and services.